Genomic Testing for Improved Treatments in Breast Cancer - Episode 7

Real-World Evidence in Genomic Testing from SABCS 2023

,

Experts in breast cancer outline data presented at SABCS 2023, focusing on real-world evidence for genomic assays used in practice.

EP. 1: Evolving Treatment Paradigms for Early-Stage Breast Cancers
EP. 2: Overview of Genomic Assays for Early-Stage Breast Cancer
EP. 3: MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer
EP. 4: Clinical Considerations of Genomic Testing in Early-Stage Breast Cancer
EP. 5: FLEX Trial: Genomic Testing of HER2 Status in ER+/HER2-Breast Cancer
EP. 6: Exploring Multigene Genomic Assays in High-Risk BC Patients
Now Viewing
EP. 7: Real-World Evidence in Genomic Testing from SABCS 2023
EP. 8: Racial Disparities and Genomic Testing for Breast Cancer Patients
EP. 9: Reflecting on Genomic Testing in Practice for Breast Cancer
EP. 10: Ongoing Studies in Genomic Testing for Breast Cancer

Related Content:

Genomic Testing for Improved Treatments in Breast CancerInsightsBreast CancerInsights Video Series
Dr Zakalik on the Role of Genetic Testing to Guide Breast Cancer Treatment
Dr Montero on Potential Advantages With STX-478 in PI3Kα-Mutant Solid Tumors
(Z)-endoxifen Reduces MBD, Is Well Tolerated in Premenopausal Women Screened for Breast Cancer